Companies / Neumora Therapeutics, Inc.

Neumora Therapeutics, Inc.

Nasdaq: NMRACIK 1885522WATERTOWN, MA

Financials

Revenue—
Net income$-236.93M
Total debt$52.96M
Cash$147.07M
Diluted EPS$-1.45
Shares outstanding185.3M

Ownership

185.3M shares outstanding · as of May 1, 2026
4.1%Insiders
Ownership
Insiders4.08%7,556,772
Institutions40.82%75,633,047
Public float55.10%102,094,425

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
Berns Paul LSee Remarks · Director
3.99%7,395,185
Aurora Daljit SinghSee Remarks
0.04%82,770
Pinto JoshuaPresident
0.03%57,783
Milligan Michael LeeSee Remarks
0.01%21,034
Duncan JasonSee Remarks
——
Fust Matthew KDirector
——

Institutional holders 109

View all →
HolderValue% of shares
BlackRock, Inc.$13.25M4.21%
SoftBank Group Corp.$11.88M3.29%
Siren, L.L.C.$11.26M3.39%
Perceptive Advisors LLC$9.95M2.75%
Vanguard Group Inc$8.13M2.45%
MIC Capital Management UK LLP$7.98M2.41%
Point72 Asset Management, L.P.$6.58M1.98%
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST$6.45M1.79%
Fmr LLC$6.26M1.89%
Millennium Management LLC$5.37M1.49%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 17, 2026Berns Paul L
Executive
SellCommon Stock$34.5K-10K
-0.13%
7,395,185
3.99% of shares
low
Feb 17, 2026Aurora Daljit Singh
Executive
SellCommon Stock$21.9K-6K
-6.93%
82,770
0.04% of shares
low
Feb 17, 2026Pinto Joshua
Executive
SellCommon Stock$21.1K-6K
-9.36%
57,783
0.03% of shares
low
Feb 17, 2026Milligan Michael Lee
Executive
SellCommon Stock$5.1K-1K
-6.39%
21,034
0.01% of shares
low
May 27, 2026Fust Matthew K
Director
GrantStock Option (Right to Buy)—+80K
80,000
0.04% of shares
low
Jan 8, 2026Milligan Michael Lee
Executive
GrantStock Option (Right to Buy)—+350K
350,000
0.19% of shares
low
Jan 8, 2026Pinto Joshua
Executive
GrantStock Option (Right to Buy)—+1.2M
1,200,000
0.65% of shares
low
Jan 8, 2026Aurora Daljit Singh
Executive
GrantStock Option (Right to Buy)—+750K
750,000
0.40% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
K2 HealthVentures Equity Trust LLCPassive13G/A———
Invus, L.P.Passive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
NMRACommon StockEquity640979100BBG012W9C4X1